$50.33 −$0.08 (-0.16%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $50.33 0.00%
开盘$49.07
昨收$50.41
当日区间$48.94 – $50.74
成交量3.19M
市值$100.88B
市盈率（TTM）17.5
股息率3.56%
基本面
最新报告季度：Q3, ended Sep 2026 · 报告货币为GBP
营收£8.89B+4.0% YoY
营业利润£2.13B-18.0% YoY
净利润£1.70B-20.6% YoY
摊薄每股收益£0.76-22.8% YoY
自由现金流£2.28B+69.5% YoY
经营现金流£2.81B
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率72.6%
营业利润率19.1%
净利率13.0%
净资产收益率24.9%
资产收益率6.5%
投入资本回报率13.1%
流动比率0.86
负债/资产比率74.4%
现金及投资£2.96B
总负债£21.70B
净现金（净负债）-£18.74B
自由现金流/营收18.7%
该公司以本国货币报告财务数据，并非美元。以下数字均标注了实际货币单位，未自动换算。
利润表
| 项目 | 2026 Q3 (GBP) |
2026 Q2 (GBP) |
2026 Q1 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
|---|---|---|---|---|---|
| 报告营业总收入 | £8.89B | £8.41B | £7.63B | £32.67B | £8.62B |
| 营业总收入 | £8.89B | £8.41B | £7.63B | £32.67B | £8.62B |
| 营业成本 | £2.39B | £2.27B | £1.88B | £9.02B | £2.66B |
| 毛利润 | £6.50B | £6.14B | £5.75B | £23.65B | £5.96B |
| 营业费用 | £4.37B | £5.66B | £3.46B | £15.31B | £4.46B |
| 销售及管理费用 | £2.38B | £2.20B | £2.12B | £9.09B | £2.64B |
| -管理费用 | £2.38B | £2.20B | £2.12B | £9.09B | £2.64B |
| 研发费用 | £1.98B | £3.47B | £1.69B | £7.53B | £2.35B |
| 其他营业费用 | £262.00M | £198.00M | – | – | – |
| 营业利润 | £2.13B | £481.00M | £2.29B | £8.34B | £1.51B |
| 非经营性利息净收入（支出） | -£190.00M | -£124.00M | -£145.00M | -£633.00M | -£250.00M |
| 非经营性利息收入 | £29.00M | £58.00M | £22.00M | £56.00M | -£74.00M |
| 非经营性利息支出 | £219.00M | £182.00M | £167.00M | £687.00M | £174.00M |
| 税前利润 | £1.94B | £354.00M | £2.14B | £7.40B | £950.00M |
| 税费 | £232.00M | -£199.00M | £305.00M | £1.11B | £223.00M |
| 净利润 | £1.70B | £553.00M | £1.84B | £6.29B | £727.00M |
| 持续经营利润 | £1.70B | £553.00M | £1.84B | £6.29B | £727.00M |
| 少数股东权益 | £160.00M | £118.00M | £102.00M | £573.00M | £91.00M |
| 归属母公司净利润 | £1.54B | £435.00M | £1.74B | £5.72B | £636.00M |
| 其他优先股股息 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
| 归属普通股股东净利润 | £1.54B | £435.00M | £1.74B | £5.72B | £636.00M |
| 基本每股收益 | £0.77 | £0.22 | £0.86 | £2.82 | £0.32 |
| 摊薄每股收益 | £0.76 | £0.21 | £0.85 | £2.78 | £0.31 |
| 每股股息 | £0.33 | £0.34 | £0.35 | £1.29 | £0.33 |
| 其他财务成本合计 | – | – | – | £2.00M | – |
| 特殊收益（费用） | – | – | – | -£813.00M | – |
| -减：重组及并购费用 | – | – | – | £581.00M | – |
| -减：其他特殊支出 | – | – | – | £232.00M | – |
资产负债表
| 项目 | 2026 Q3 (GBP) |
2026 Q2 (GBP) |
2026 Q1 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
|---|---|---|---|---|---|
| 总资产 | £71.70B | £61.74B | £62.87B | £61.12B | £61.12B |
| 流动资产合计 | £17.90B | £17.56B | £17.76B | £17.51B | £17.51B |
| 现金及现金等价物与短期投资 | £2.96B | £3.11B | £3.44B | £3.16B | £3.16B |
| -现金及现金等价物 | £2.93B | £3.11B | £3.44B | £3.15B | £3.15B |
| -短期投资 | £28.00M | £1.00M | £1.00M | £9.00M | £9.00M |
| -应收账款 | £8.22B | £7.71B | £7.76B | £5.91B | £5.91B |
| -应收税款 | £302.00M | £368.00M | £181.00M | £799.00M | £799.00M |
| 存货 | £6.30B | £6.28B | £6.16B | £5.92B | £5.92B |
| 非流动资产合计 | £53.80B | £44.18B | £45.11B | £43.61B | £43.61B |
| 固定资产净值 | £10.12B | £10.03B | £10.04B | £10.05B | £10.05B |
| -固定资产原值 | £10.12B | £10.03B | £10.04B | £20.94B | £20.94B |
| -长期股权投资 | £49.00M | £101.00M | £99.00M | £89.00M | £89.00M |
| 金融资产 | £54.00M | £17.00M | £19.00M | £0.00 | £0.00 |
| 商誉及其他无形资产 | £33.39B | £24.18B | £25.43B | £23.77B | £23.77B |
| -商誉 | £8.22B | £7.38B | £7.29B | £7.02B | £7.02B |
| -其他无形资产 | £25.17B | £16.80B | £18.14B | £16.75B | £16.75B |
| 其他非流动资产 | £2.64B | £2.65B | £2.36B | – | – |
| 负债合计 | £53.34B | £44.56B | £45.45B | £45.16B | £45.16B |
| 流动负债合计 | £20.72B | £21.53B | £22.43B | £21.39B | £21.39B |
| 应付款 | £16.31B | £14.87B | £14.89B | £4.47B | £4.47B |
| -应付账款 | £15.63B | £14.34B | £14.34B | £3.54B | £3.54B |
| -应付税款合计 | £678.00M | £524.00M | £555.00M | £498.00M | £498.00M |
| 短期债务及融资租赁负债 | £2.00B | £4.29B | £5.04B | £3.01B | £3.01B |
| 一年内预提费用 | £926.00M | £844.00M | £908.00M | £938.00M | £938.00M |
| 其他流动负债 | £1.32B | £1.38B | £1.40B | £1.35B | £1.35B |
| 非流动负债合计 | £32.62B | £23.03B | £23.02B | £23.77B | £23.77B |
| 长期债务及融资租赁负债 | £21.70B | £13.95B | £14.01B | £14.71B | £14.71B |
| 衍生产品负债 | £101.00M | £55.00M | £56.00M | £67.00M | £67.00M |
| 非流动负债 | £751.00M | £610.00M | £579.00M | £610.00M | £610.00M |
| 其他非流动负债 | £6.84B | £6.49B | £6.32B | £5.39B | £5.39B |
| 股东权益合计 | £18.36B | £17.18B | £17.42B | £15.96B | £15.96B |
| 股东权益 | £18.75B | £17.65B | £17.85B | £16.38B | £16.38B |
| 股本 | £1.35B | £1.35B | £1.35B | £1.35B | £1.35B |
| -普通股 | £1.35B | £1.35B | £1.35B | £1.35B | £1.35B |
| 资本公积 | £3.51B | £3.51B | £3.51B | £3.50B | £3.50B |
| 留存收益 | £12.46B | £11.46B | £11.59B | £10.21B | £10.21B |
| 少数股东权益 | -£392.00M | -£468.00M | -£430.00M | -£421.00M | -£421.00M |
| 长期应付账款及其他应付款 | – | – | £66.00M | £896.00M | £896.00M |
| -其他应收款 | – | – | – | £662.00M | £662.00M |
| 预付资产 | – | – | – | £385.00M | £385.00M |
| 受限现金 | – | – | – | £247.00M | £247.00M |
| -累计折旧 | – | – | – | -£10.89B | -£10.89B |
| -可供出售证券 | – | – | – | £790.00M | £790.00M |
| 设定受益养老金 | – | – | – | £1.12B | £1.12B |
| -其他应付款 | – | – | – | £438.00M | £438.00M |
| -一年内到期债务 | – | – | – | £2.88B | £2.88B |
| -一年内到期融资租赁负债 | – | – | – | £137.00M | £137.00M |
| 一年以上应计费用 | – | – | – | £6.00M | £6.00M |
| -长期债务 | – | – | – | £14.02B | £14.02B |
| -长期融资租赁负债 | – | – | – | £693.00M | £693.00M |
| 其他权益权益 | – | – | – | -£282.00M | -£282.00M |
现金流量表
| 项目 | 2026 Q3 (GBP) |
2026 Q2 (GBP) |
2026 Q1 (GBP) |
2025 ANNUAL (GBP) |
2025 Q4 (GBP) |
|---|---|---|---|---|---|
| 经营活动现金流 | £2.81B | £2.69B | £1.14B | £7.74B | £2.28B |
| 持续经营净利润 | £1.70B | £553.00M | £1.84B | £6.29B | £727.00M |
| 递延税款 | £232.00M | -£199.00M | £305.00M | £1.11B | £223.00M |
| 其他非现金项目 | £190.00M | £124.00M | £145.00M | £568.00M | £185.00M |
| 营运资金变动 | £567.00M | £560.00M | -£1.08B | -£1.44B | £872.00M |
| -其他流动资产变动 | -£423.00M | – | – | -£1.14B | £886.00M |
| -其他流动负债变动 | £990.00M | – | – | £465.00M | £749.00M |
| 投资活动现金流净额 | -£7.71B | -£789.00M | -£1.47B | -£4.23B | -£933.00M |
| 固定资产购置及出售净额 | -£371.00M | -£325.00M | -£194.00M | -£1.32B | -£560.00M |
| 无形资产购置及出售净额 | -£158.00M | -£32.00M | -£160.00M | -£1.52B | -£449.00M |
| 业务购买及出售净额 | -£7.15B | -£526.00M | -£1.17B | -£1.64B | -£31.00M |
| 投资购置及出售净额 | -£29.00M | £0.00 | £9.00M | £11.00M | £0.00 |
| 筹资活动现金流 | £4.67B | -£2.15B | £272.00M | -£3.69B | -£856.00M |
| 债务发行及偿还净额 | £5.42B | -£632.00M | £1.18B | £1.51B | £548.00M |
| 普通股发行净额 | £0.00 | -£307.00M | -£318.00M | -£1.36B | -£251.00M |
| 已付现金股利 | -£682.00M | -£727.00M | -£643.00M | -£2.56B | -£646.00M |
| 其他筹资费用净额 | £166.00M | -£35.00M | £1.70B | £46.00M | -£25.00M |
| 期末现金余额 | £2.68B | £2.94B | £3.20B | £3.21B | £3.21B |
| 现金净变动 | -£229.00M | -£248.00M | -£53.00M | -£177.00M | £489.00M |
| 期初现金余额 | £2.94B | £3.20B | £3.25B | £3.40B | £2.76B |
| 汇率变动影响 | -£34.00M | -£7.00M | £2.00M | -£19.00M | -£41.00M |
| 自由现金流 | £2.28B | £2.04B | £698.00M | £4.76B | £1.25B |
| -应收款变动 | – | – | – | -£1.10B | – |
| -存货变动 | – | – | – | -£140.00M | – |
暂无评论——快来第一个聊聊 GSK。
登录后参与讨论。